ema semaglutide naion label update 2025 Novo's Ozempic linked to rare cases of serious eye disorder, EU regulator says Ozempic Blindness Lawsuit [2026 Guide]
Description
Its receptor binding profile shows that it binds to GIP receptors with an affinity similar to the natural hormone but has a fivefold lower affinity for GLP-1 receptors
![ema semaglutide naion label update 2025 Novo's Ozempic linked to rare cases of serious eye disorder, EU regulator says Ozempic Blindness Lawsuit [2026 Guide]](https://trulaw.com/wp-content/uploads/2025/11/Qualifying-Criteria-and-Medical-Requirements.webp)
Rx required.
![ema semaglutide naion label update 2025 Novo's Ozempic linked to rare cases of serious eye disorder, EU regulator says Ozempic Blindness Lawsuit [2026 Guide]](https://www.ophthalmology-now.co.uk/_next/image?url=https%3A%2F%2Fmedia.caboodleai.net%2Ftrendingnowoptics%2F19a%2F1e801fb7-3015-46df-9b4f-d878de93aea1.jpg&w=3840&q=75)
The orally disintegrating tablet is convenient and easy to take, relieving your nausea without the stromach distress
![ema semaglutide naion label update 2025 Novo's Ozempic linked to rare cases of serious eye disorder, EU regulator says Ozempic Blindness Lawsuit [2026 Guide]](https://onlinelibrary.wiley.com/cms/asset/6e10403b-ae42-4579-9851-d633c79b33d7/aos.v103.6.cover.jpg)
Complete form
![ema semaglutide naion label update 2025 Novo's Ozempic linked to rare cases of serious eye disorder, EU regulator says Ozempic Blindness Lawsuit [2026 Guide]](https://www.reuters.com/resizer/v2/YQ2BF4YYFRIWNIE2XFDP5K6ARQ.jpg?auth=7590204bb1ae78336e2155679ff0840519fb1fb5a8cd2fd3d3a97813190c05a3&height=1200&width=1200&quality=80&smart=true)
Moreover, GLP-1 RAs have been shown to protect against oxidative stress, cellular senescence and chronic inflammation, which are widely accepted as the major risk factors of aging